Milestone Pharmaceuticals Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -6,336.1% | – | – | – | -826.3% | -6,745.0% | -4,031.1% | -2,611.1% | |
| – | – | – | – | – | 24.1% | – | – | – | 2.2% | 23.5% | 10.2% | 7.3% | |
| – | – | – | – | – | 1,364.8% | – | – | – | 229.8% | 538.7% | 560.6% | 393.4% | |
| – | – | – | – | – | 2,980.6% | – | – | – | 1.8% | 1,908.0% | -42.1% | 181.6% | |
| – | – | – | – | – | 20.4% | – | – | – | 0.7% | 18.9% | 4.6% | 3.6% | |
| – | – | – | – | – | 17,901.9% | – | – | – | 174.8% | -33,626.1% | 20,007.8% | -48.3% | |
| – | – | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | 22.2% | – | – | – | 2,356.6% | 39,644.5% | 1,547.7% | 8,070.9% | |
| – | – | – | – | – | 11,588.0% | – | – | – | 1,705.1% | -726.5% | 17,604.8% | 5,430.2% | |
| – | – | – | – | – | -6,356.5% | – | – | – | -827.0% | -6,745.0% | -4,035.7% | -2,612.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.